The lymph node as a bridgehead in the metastatic dissemination of tumors.
The metastatic spread of tumors is not a random process. Distinct patterns of metastasis can be discerned which vary from tumor type to tumor type. A common pattern, particularly for carcinomas, is that regional lymph nodes are often the first organs to develop metastases. This pattern of metastasis is central to the utility of the sentinel lymphonodectomy surgical technique. However, not all tumors and tumor types metastasize first to the regional lymph nodes. The mechanisms which determine whether regional lymph nodes or other sites first develop metastases remain poorly understood. In this article I review the anatomical, cellular and molecular factors which play a role in metastatic dissemination and determine patterns of metastasis. I then explore the importance of tumor heterogeneity and the selection of metastatically competent tumor cells during systemic dissemination, and suggest that some secondary sites are more readily colonised by metastasizing cells than others. Metastases at these sites act as bridgeheads, constituting a reservoir of tumor cells which, because they have already successfully metastasized, possess many of the properties required for metastasis to further sites. These tumor cells are therefore more likely than cells in the primary tumor to acquire all of the properties required for metastasis to less favourable secondary sites. To illustrate the bridgehead concept, I argue that features of the design and function of the lymphatic system make it highly amenable to the entry of metastasizing tumor cells and the formation of lymph node metastases, and suggest that lymph node metastases form a bridgehead for further metastatic spread.
Sleeman
J P
JP
Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Germany.
D000818:Animals; D002448:Cell Adhesion; D002465:Cell Movement; D010450:Endopeptidases / Q000096:biosynthesis / Q000502:physiology; D004789:Enzyme Activation; D004790:Enzyme Induction; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000503:physiopathology*; D008208:Lymphatic System / Q000473:pathology; D008954:Models, Biological; D009154:Mutation; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D009363:Neoplasm Proteins / Q000502:physiology; D009369:Neoplasms / Q000235:genetics / Q000473:pathology*; D009360:Neoplastic Cells, Circulating; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology; D009389:Neovascularization, Pathologic; D009928:Organ Specificity; D051381:Rats; D021701:Sentinel Lymph Node Biopsy
D009363:Neoplasm Proteins; D010450:Endopeptidases